Prudential Financial’s Immunovant IMVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-35,349
Closed -$1.14M 2742
2024
Q1
$1.14M Sell
35,349
-25,381
-42% -$820K ﹤0.01% 1750
2023
Q4
$2.56M Buy
60,730
+35,890
+144% +$1.51M ﹤0.01% 1284
2023
Q3
$954K Sell
24,840
-48,400
-66% -$1.86M ﹤0.01% 1790
2023
Q2
$1.39M Sell
73,240
-50,390
-41% -$956K ﹤0.01% 1633
2023
Q1
$1.92M Buy
123,630
+6,900
+6% +$107K ﹤0.01% 1368
2022
Q4
$2.07M Buy
116,730
+350
+0.3% +$6.21K ﹤0.01% 1290
2022
Q3
$650K Buy
+116,380
New +$650K ﹤0.01% 1953
2021
Q2
Sell
-18,114
Closed -$290K 2591
2021
Q1
$290K Buy
18,114
+13,436
+287% +$215K ﹤0.01% 2282
2020
Q4
$217K Buy
+4,678
New +$217K ﹤0.01% 2338